Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Bradley A. Keywell Sells 265,000 Shares

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) major shareholder Bradley A. Keywell sold 265,000 shares of Tempus AI stock in a transaction dated Friday, January 17th. The stock was sold at an average price of $35.10, for a total value of $9,301,500.00. Following the completion of the transaction, the insider now owns 15,218,365 shares of the company's stock, valued at $534,164,611.50. This trade represents a 1.71 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

Tempus AI Stock Up 1.2 %

Shares of TEM stock traded up $0.40 during trading on Friday, reaching $35.15. The company's stock had a trading volume of 2,434,717 shares, compared to its average volume of 3,919,255. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $79.49. The business has a fifty day moving average price of $46.80 and a 200-day moving average price of $47.09. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Institutional Investors Weigh In On Tempus AI

A number of large investors have recently added to or reduced their stakes in TEM. SG Americas Securities LLC acquired a new stake in Tempus AI during the fourth quarter worth approximately $372,000. Dakota Wealth Management raised its stake in Tempus AI by 189.7% in the 4th quarter. Dakota Wealth Management now owns 60,668 shares of the company's stock worth $2,048,000 after purchasing an additional 39,724 shares in the last quarter. Avanza Fonder AB acquired a new position in shares of Tempus AI during the 4th quarter worth approximately $1,197,000. Bouvel Investment Partners LLC bought a new position in shares of Tempus AI during the fourth quarter worth approximately $1,029,000. Finally, FNY Investment Advisers LLC acquired a new stake in Tempus AI during the fourth quarter worth approximately $67,000. Institutional investors own 24.22% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on TEM shares. Needham & Company LLC restated a "buy" rating and set a $56.00 price objective on shares of Tempus AI in a research report on Tuesday. Loop Capital reduced their price objective on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a report on Tuesday. Piper Sandler restated a "neutral" rating and issued a $70.00 target price (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Wolfe Research assumed coverage on Tempus AI in a research note on Friday, December 13th. They issued an "outperform" rating and a $60.00 price target on the stock. Finally, Bank of America raised their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the company a "neutral" rating in a research report on Friday, December 13th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $56.36.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.